- Home
- HROW
HROW
Harrow Inc.
as 03-28-2025 4:00pm EST
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | NASHVILLE |
| Market Cap: | 1.0B | IPO Year: | N/A |
| Target Price: | $55.40 | AVG Volume (30 days): | 661.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.86 - $59.23 | Next Earning Date: | 03-27-2025 |
| Revenue: | $199,614,000 | Revenue Growth: | 53.32% |
| Revenue Growth (this year): | 49.78% | Revenue Growth (next year): | 47.09% |
Latest Harrow Inc. News
HROW Breaking Stock News: Dive into HROW Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results
Business Wire
2 days ago
Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025
Simply Wall St.
2 days ago
Harrow And 2 Insider Picks For Growth Potential
Business Wire
5 days ago
Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL
GuruFocus.com
7 days ago
What To Expect From Harrow Inc (HROW) Q4 2024 Earnings
Business Wire
12 days ago
Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance
Business Wire
12 days ago
Harrow Launches VEVYE® Access for All
Business Wire
18 days ago
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
Compare HROW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HROW Harrow Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.